Bayer/J&J eye new pediatric use for anticoagulant Xarelto

Bayer/J&J eye new pediatric use for anticoagulant Xarelto

Source: 
Pharmaforum
snippet: 

Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) has been shown to prevent recurrence of thromboembolism in children, paving the way for a potential new indication for the anticoagulant.